您当前的位置:
首页 >
文章列表页 >
Discussion on the treatment of myelodysplastic syndrome from the perspective of the liver guided by Treatise On Blood Syndromes
更新时间:2023-02-02
    • Discussion on the treatment of myelodysplastic syndrome from the perspective of the liver guided by Treatise On Blood Syndromes

    • Modern Chinese Clinical Medicine   Vol. 30, Issue 1, Pages: 84-86(2023)
    • DOI:10.3969/j.issn.2095-6606.2023.01.020    

      CLC: R259
    • Received:01 December 2021

      Published:30 January 2023

    移动端阅览

  • LIU Jian, LI Rui, MAO Yue, et al. Discussion on the treatment of myelodysplastic syndrome from the perspective of the liver guided by Treatise On Blood Syndromes[J]. Modern Chinese Clinical Medicine, 2023, 30(1): 84-86. DOI: 10.3969/j.issn.2095-6606.2023.01.020. DOI:

  •  
  •  
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

0

Views

794

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

A case report: a severe anemia patient with advanced gastric cancer complicated with myelodysplastic syndrome treated by integrated Traditional Chinese and Western medicine
Thoughts and methods of differentiation and treatment of senile high-risk myelodysplastic syndrome
陈信义教授“调平”思想论治MDS经验
Academic connotation and clinical value of Lei Shaoyi' s method of regulating lung function to dispel summer pathogenic factors
Investigating the dissemination capacity of latent pathogenic cancer toxins through the lens of exosome-stromal connectivity

Related Author

LIU Zhu
LI Xiao
FANG Zhenzhen
LIU Aiqi
SHEN Yang
DONG Qing
XU Jing
YUN Zhangjun

Related Institution

Department of Oncology and Hematology, Dongzhimen Hospital, Beijing University of Chinese Medicine
Dongzhimen Hospital of Beijing University of Chinese Medicine
0